Trial In Progress: An Open-Label, Global, Multicenter, Phase 1B/2 Study Of Tl-895, A Bruton'S Tyrosine Kinase Inhibitor (Btki), Added To Ruxolitinib (Rux) In Patients (Pts) With Myelofibrosis (Mf)
Ruxolitinib;TL-895
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Trial In Progress: An Open-Label, Global, Multicenter, Phase 1B/2 Study Of Tl-895, A Bruton'S Tyrosine Kinase Inhibitor (Btki), Added To Ruxolitinib (Rux) In Patients (Pts) With Myelofibrosis (Mf) ### Output: Ruxolitinib;TL-895